Abiopharma

News list

McCulloch Kevin 🔴 sold 21.9K shares of Xeris Biopharma Holdings, Inc. (XERS) at $8.08 Transaction Date: Aug 01, 2026 | Filing ID: 000069

Full text

News bot Aug. 21, 2026, 8:16 p.m.
🔍 McCulloch Kevin (Executive)

Company: Xeris Biopharma Holdings, Inc. (XERS)

Report Date: 2026-08-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 21,918
- Total shares held: 25,000
Detailed Transactions and Holdings:
- Sold 21,918 shares of Common Stock at $8.08 per share (Direct)
  Date: 2026-08-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,654,208.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-01 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 25,000.00 | Footnotes: F2
Footnotes:
- F1: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026.
- F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- REMARKS: President and Chief Operating Officer